US Pivotal Clinical Study of the Adient Absorbable Filter for the Prevention of Pulmonary Embolism

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 854 participants.

Also called NCT05127915

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 854 participants (planned count) (from the registry)
Sponsor
  • Avania Registry lists this organization as a collaborator
  • ICON plc Registry lists this organization as a collaborator
Registry
  • NCT NCT05127915
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05127915. Randomized; single masking; primary purpose prevention. Start 2023-01-27 (actual); primary completion 2026-05-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
US Pivotal Clinical Study of the Adient Absorbable Filter for the Prevention of Pulmonary Embolism
Intervention (Device)
Adient absorbable filter + best practice VTE prophylaxis
Intervention (Device)
best practice VTE prophylaxis
Lead sponsor
Adient Medical (class: industry)
Collaborator
Avania (class: industry)
Collaborator
ICON plc (class: industry)

Record details

Record id
cardio:ct-nct05127915
Content hash
678e63ce8bb6e22c7f05f2c71bf05609b71d1d75b43d28edee9f084b41836553